Ag-Tenofovir 300 mg (Tenofovir Disoproxil Fumarate TABLET) 300 MG

AG-Tenofovir 300 mg tablets contain Tenofovir Disoproxil Fumarate, an antiretroviral medication used to manage HIV. This oral tablet is manufactured by Angita Pharma Inc. in Canada.

Strength

300 MG

Manufacturer / TM Owner

ANGITA PHARMA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AG-Tenofovir 300 mg tablets are primarily used as part of antiretroviral therapy to treat HIV infection. Tenofovir Disoproxil Fumarate works by inhibiting the reverse transcriptase enzyme, which is essential for the HIV virus to replicate. This medication is often combined with other antiretroviral drugs to manage HIV effectively. What is Tenofovir Disoproxil Fumarate used for? It is used to control HIV infection and reduce the risk of complications associated with the virus.

Side Effects

Common effects of AG-Tenofovir 300 mg tablets may include nausea, diarrhea, and headache. Some individuals might experience dizziness or fatigue. These effects vary among users and are not experienced by everyone. It is important to consult a healthcare provider if any effects are severe or persistent.

Precautions & Warnings

AG-Tenofovir 300 mg tablets should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Keep the tablets out of reach of children and pets. Always follow the instructions provided by your healthcare provider for safe usage.

Avoid Interactions

AG-Tenofovir 300 mg tablets may interact with other medications, including certain antibiotics, antiviral drugs, and medications that affect kidney function. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy of the medication.

Frequently Asked Questions

AG-Tenofovir 300 mg tablets are used as part of antiretroviral therapy to manage HIV infection.

AG-Tenofovir 300 mg tablets are taken orally, typically once daily. Follow the instructions provided by your healthcare provider.

Common side effects may include nausea, diarrhea, headache, dizziness, and fatigue.

Consult your healthcare provider before consuming alcohol while taking AG-Tenofovir 300 mg tablets.

AG-Tenofovir 300 mg tablets are manufactured by Angita Pharma Inc. in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.